Herold Advisors, Inc. Mustang Bio, Inc. Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$0.58 - $1.13 $2,320 - $4,520	-4,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.73 - $1.81 $2,920 - $7,240	4,000 New	4,000 $4,000
Q4 2021 Jan 20, 2022	SELL	$1.66 - $2.64 $6,640 - $10,560	-4,000 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$2.58 - $3.36 $10,320 - $13,440	4,000 New	4,000 $10,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.